TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/06/2026
Back to search
Official data from USPTO
MINARIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MINARIS
ST13
US500000090030815Class
40, 42, 44
Filing
90030815
Registration
6799894
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
01/08/2026
Trademark type
Word
Nice classes
40, 42, 44
Filing date
07/01/2020
Registration date
07/26/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/26/2022
Last transaction
01/08/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
29
Owner location
KANAGAWA, JP
Examiner
STRUCK,ROBERT J
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
MINARIS REGENERATIVE MEDICINE CO., LTD.
R. C. (pessoa física)
SHOWA DENKO MATERIALS CO., LTD.
HITACHI CHEMICAL COMPANY, LTD.
Representatives
KATE SHERLOCK ARCHER & GREINER, P.C.
Technical classification
Nice Classes
Class 40Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Contract manufacturing in the field of biological cells; contract manufacturing of cell tissue; contracted biological cell processing; informationadvice and consultancy services relating to biological cell manufacturing; contract manufacturing in the field of biologics and pharmaceuticals; contracted cell culturing and tissue culturing in the nature of custom processing and manufacturing in the field of biological cells and tissues; advisory services in the field of cell culturing in the nature of advisory services in the field of custom processing and manufacturing in the field of biological cells; contract manufacturing of cell therapieshematopoietic and immune system cellsgenetically or otherwise modified cellscells which are propagatedcultivated and expanded in bioreactorscells for the purpose of tissue regeneration
Class 42
quality control services in the field of cell culture and tissue cultureconsultancy relating thereto; quality control of cell and living tissue for others; Pharmaceutical research and development servicescontracted cell culturing and tissue culturing for scientific purposes; scientific and technological servicestestinginspection for quality control purposesresearch in the field of cell culture and tissue cultureconsultancy and information services relating thereto; pharmaceutical research and development advisory servicesadvisory services in the field of cell culturing for scientific purposes; research and product development services in the field of cell culture and tissue cultureconsultancy relating thereto; scientific consulting and research services relating to the isolation and cultivation of body tissues and cells; advisory services for pharmaceutical drug development; scientific testing and research services in the field of pharmaceuticals and biotechnologyadvisory services relating thereto; contracted development of biological cell manufacturing process; scientific laboratory servicesthe cultivation or modification of hematopoietic and immune system cellsgenetically or otherwise modified cellscells which are propagatedcultivated and expanded in bioreactorscells for the purpose of tissue regeneration into living drugs
Class 44
Medical servicescontracted cell culturing and tissue culturing for medical purposes; medical advisory servicesadvisory services in the field of contracted cell culturing and tissue culturing for medical purposes; medical servicesseparation and cultivation of body tissues and cells for medical purposes; informationadvice and consultancy services relating to medical services and regenerative medicine; human tissue bank services; providing medical information; medicalmedicinal and pharmaceutical consultancy; isolationcollection and preservation of blood components including cells or stem cells obtained from umbilical cord bloodbone marrowplacenta and other parts of the human bodyhematopoietic and immune system cellsgenetically or otherwise modified cellscells which are propagatedcultivated and expanded in bioreactorscells for the purpose of tissue regenerationcells of human or animal origin
Publications
History of USPTO decisions and trademark events.
38 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01/06/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/06/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/06/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/06/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/06/2026
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/05/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/19/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/19/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/19/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/19/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/19/2025
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
07/11/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/03/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/26/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
07/26/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/10/2022
PUBO
PUBLISHED FOR OPPOSITION
05/10/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/20/2022
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
04/04/2022
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
04/01/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/31/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/02/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/02/2022
ALIE
ASSIGNED TO LIE
03/02/2022
ALIE
ASSIGNED TO LIE
03/01/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/28/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
08/31/2021
GNSI
INQUIRY TO SUSPENSION E-MAILED
08/31/2021
CNSI
SUSPENSION INQUIRY WRITTEN
08/31/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
07/28/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/06/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/06/2020
GNSL
LETTER OF SUSPENSION E-MAILED
10/06/2020
CNSL
SUSPENSION LETTER WRITTEN
10/06/2020
DOCK
ASSIGNED TO EXAMINER
10/06/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/29/2020
NWAP
NEW APPLICATION ENTERED
07/04/2020
Continuous trademark protection
Get notified about every new filing that threatens MINARIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.